CLINICAL_TRIALS
withdrawal
· 2018-06-07
Clinical Trial Update: Effects of rTMS and tDCS Treatment on Brain Function, Craving and Relapse Prevention [NA]
Summary
The trial evaluating rTMS and tDCS for brain function, craving, and relapse prevention in individuals with substance use disorder has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Medical University of South Carolina | Conditions: Addiction | NA | Status: WITHDRAWN